Utilized the Trial Companion Kit and Retention & Adherence Support Series to maintain 95% patient retention in a complex, long-term rare disease study.
A pediatric rare disease trial faced the risk of high dropout due to the study's two-year duration, complex at-home dosing, and the emotional burden on patient families. Retention was projected to fall below 80% without intervention.
Emily Waltson
Mid-size Biopharma / Phase IIb Pediatric
"The Trial Companion Kit was essential—it became the family's single source of truth. The milestone recognition truly made participants feel valued, sustaining motivation throughout the multi-year commitment."
Team behind Poppin
What we did
Achieved a 95% retention rate over 24 months; 8% increase in patient-reported adherence accuracy; 100% positive feedback on the Trial Companion Kit.
12
Pages
5
CMS Layouts
3
Awards
Project approach
We designed a comprehensive Trial Companion Kit (including personalized visual roadmaps, key contact cards, and gamified patient journals) and paired it with the Retention & Adherence Support Series (milestone recognition and automated reminders). This holistic approach provided continuous support and motivation, which is key to long-term studies.
%402x.svg)
%402x.svg){kind=icon}
%402x%20(dark).svg){kind=icon}
%402x%20(dark).svg){kind=icon}
%402x.svg){kind=icon}